Novartis India Limited
Share Price Target & Analysis
NSE:NOVARTIND
VWAP
Open
Close
High
Low
52 Week High
-203.30 (-8.5%)
NOVARTIND
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: NOVARTIND Share Price Financial Analysis & Valuation
Novartis India Limited (NOVARTIND) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Micro Cap company with Market Capitalization of Rs 1810.1 (in Cr). Total number of free float shares are 0 (in Lacs).
Novartis India Limited is listed on NSE with Exchange ID - INE234A01025 and trading code is NSE:NOVARTIND with short name Novartis India.
In the past 1 year, Novartis India Limited has declared an equity dividend of Rs 0 per share. At the current share price of NOVARTIND at Rs 2188.00, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:NOVARTIND, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NOVARTIND underlying value and future prospects. All of this data is available in NOVARTIND financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:NOVARTIND, it is clearly understood that NOVARTIND is Economical performer in terms of earnings and profit margins with an EPS of 38.53. NSE:NOVARTIND book value per share as of today is 344.28. The current price to book ratio for NOVARTIND as of Sep 15, 2026 is 6.36.
Valuation of the Stock: The current valuation of NOVARTIND stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NOVARTIND whether to BUY this stock at current valuation. The delivery percentage of NOVARTIND is 67944% is very crucial parameter which shows that 67944% investors are anticipating that the price of NOVARTIND share should go up with VWAP at 2256.75.
Now, the main question is whether to BUY or SELL, NSE:NOVARTIND at current valuation.
As per latest Analysis No. #1143:-
⇑ STRONG BUY NOVARTIND if All Greens
⇗ BUY NOVARTIND (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD NOVARTIND (With Stop Loss) if only 1 Green
⇘ SELL NOVARTIND if NO Green Indicator
NSE: NOVARTIND Share Price Today (Sep 15, 2026)
(Novartis India Limited Daily Analysis on the basis of NOVARTIND Intraday Graph & Trend)
Novartis India Limited share price moved Down by -8.5% from its previous close of Rs 2391.3. NOVARTIND stock last traded price is 2188.00. NOVARTIND share price trend is Down with a total of 135594 stocks traded till now. It has touched an intraday high of Rs 2360.2 and an intraday low of Rs 2153.3. The NOVARTIND trading at 2188.00, Down by Rs. -203.30, or -8.5 percent which suggests that most of the Traders are anticipating that the price of NOVARTIND share should go Down.
NSE: NOVARTIND Share Price Tomorrow Prediction
(Novartis India Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NOVARTIND)
Novartis India Limited share price moved Down by -8.5%. NOVARTIND share price short term trend is Down. It suggests that NOVARTIND Share Price for Tomorrow remains the same with VWAP at 2256.75 will be treated as stop loss for intraday traders. Novartis India Limited Long term investors can follow the NOVARTIND long term trend as mentiond in future forecast table.
NSE Code |
NSE: NOVARTIND |
NOVARTIND Share Price Today |
2188.00 |
NOVARTIND Share Price Target Prediction for 2026 ^ |
1704.7 - 2601.6 |
NOVARTIND Share Price Target Prediction for 2027*^ |
2601.6 - 2771.6 |
NOVARTIND Share Price Target Prediction for 2028*^ |
2771.6 - 2965.6 |
NOVARTIND Share Price Target Prediction for 2029*^ |
3114 |
NOVARTIND Share Price Target Prediction for 2030*^ |
3203 |
NOVARTIND Share Price Target Prediction for 2035*^ |
3491 |
| NOVARTIND Current Book Value |
342.6 |
*Novartis India Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^NOVARTIND share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
NOVARTIND Technical Analysis (In Process... .. .)
Please wait for a while and refresh the page to check again.
Most popular Questions & Answers about NOVARTIND (/ FAQ NOVARTIND)
Novartis India Limited stock last traded price is 2188.00. NOVARTIND share price moved Down by -8.5% from its previous close of Rs 2391.3.
Novartis India Limited share price trend is Down with a total of 135594 stocks traded till now. It has touched an intraday high of Rs 2614.688 and an intraday low of Rs 2153.3. The NOVARTIND trading at 2188.00, Down by Rs. -203.30, or -8.5 percent which suggests that most of the Traders are anticipating that the price of NOVARTIND share should go Down and the Stop Loss will be around 2256.75.
The market cap of Novartis India Limited is ₹1810.1 (in Cr) as of Sep 14, 2026.
The current price to earning ratio for Novartis India Limited as of Sep 14, 2026 is 55.25.
The current price to book ratio for Novartis India Limited as of Sep 14, 2026 is 6.36.
The highest price of Novartis India Limited stock is ₹2588.8 in the last 52-week.
The lowest price of Novartis India Limited stock is ₹950 in the last 52-week.
Novartis India Limited share trading at ₹2188.00, Down by Rs. -203.30, or -8.5 percent which suggests that most of the traders are anticipating that the price of NOVARTIND share should go Down.
In 2026, Stock price target for Novartis India Limited (NOVARTIND) will be around ₹1704.7 on downside and ₹2601.6 on upside. Novartis India Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Novartis India Limited (NOVARTIND) will be around ₹2601.6 on downside and ₹2771.6 on upside. Novartis India Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Novartis India Limited (NOVARTIND) will be around ₹2771.6 on downside and ₹2965.6 on upside. Novartis India Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Novartis India Limited (NOVARTIND) will be around ₹3203 Novartis India Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NOVARTIND.
The price of Novartis India Limited (NOVARTIND) shares moved by -8.5%. The short-term trend for NOVARTIND share price is Down. It implies that the share price of NOVARTIND will stay the same tomorrow and that intraday traders should treat VWAP at 2256.75 as a stop loss. Investors with a long-term outlook can track NOVARTIND long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of NOVARTIND stock is 462. Compared to the current market price of 2188.00 INR, the NOVARTIND stock is Overvalued by 78.9%.
As per the fundamental analysis of Novartis India Limited (NOVARTIND), it is of Economical quality in terms of earnings and profit margins with an EPS of 38.53. Novartis India Limited book value per share as of today is 344.28. The current price to book ratio for NOVARTIND as of Sep 15, 2026 is 6.36.
NSE:NOVARTIND News & Other Useful Information about NOVARTIND Share Price
Peer Comparison of NSE: NOVARTIND
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1835.00 | 16.35 | 97.89 |
| DIVISLAB | 9198.00 | 115.55 | 663.06 |
| MEDICAMEQ | 318.20 | 12.15 | 208.08 |
| CIPLA | 1351.00 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4850.00 | 87.32 | 235.7 |
| BIOCON | 382.00 | 1.27 | 166.51 |
| LUPIN | 2063.20 | 154.86 | 718.37 |
| ALKEM | 5161.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1660.00 | 46.49 | 403.84 |
| ABBOTINDIA | 26125.00 | 766.11 | 2448.41 |
| GLAXO | 2818.90 | 63.65 | 147.25 |
| IPCALAB | 1932.40 | 56.72 | 329.23 |
| LAURUSLABS | 1926.90 | 20.74 | 102.57 |
| LALPATHLAB | 1906.40 | 39.68 | 157.23 |
| PFIZER | 4041.60 | 170.54 | 963.41 |
| AJANTPHARM | 3510.40 | 89.3 | 363.23 |
| SANOFI | 3131.00 | 158.05 | 332.96 |
| NATCOPHARM | 819.15 | 82.14 | 481.67 |
| APLLTD | 824.75 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2371.70 | 1.24 | 881.78 |
| AAREYDRUGS | 98.50 | 2.39 | 53.38 |
| JUBLPHARMA | 1011.95 | 4.35 | 145.63 |
| SPARC | 188.00 | 48.14 | 40.45 |
| GRANULES | 872.60 | 23.25 | 180.42 |
| ASTRAZEN | 6695.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2570.60 | 55.52 | 285.6 |
| FDC | 349.70 | 21.19 | 161.21 |
| HIKAL | 212.22 | 9.34 | 96.63 |